NCM
APYX icon

Nantahala Capital Management’s Apyx Medical APYX Stock Holding History

Nantahala Capital Management’s Portfolio APYX Stock Details APYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.7M Sell
3,270,248
-170,056
-5% -$674K 0.49% 57
2026
Q1 		$12.7M Sell
3,440,304
-533,787
-13% -$1.99M 0.47% 62
2025
Q4 		$13.9M Buy
3,974,091
+636,043
+19% +$2.22M 0.46% 54
2025
Q3 		$7.14M Hold
3,338,048
– – 0.25% 89
2025
Q2 		$7.51M Buy
3,338,048
+80,000
+2% +$113K 0.29% 67
2025
Q1 		$4.46M Buy
3,258,048
+88,248
+3% +$122K 0.18% 78
2024
Q4 		$5.01M Buy
+3,169,800
New +$4.43M 0.22% 79

Other funds holding APYX

RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $246M AUM 130.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EIM
Essex Investment Management Boston, Massachusetts $763M AUM 108.51% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
SBCM
Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
HKAM
Horizon Kinetics Asset Management New York $8.82B AUM 23.05% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Nantahala Capital Management's APYX Position: Q2 2026 in Review

Nantahala Capital Management reduced its Apyx Medical (APYX) stake by 4.9% in Q2 2026, selling an estimated $674K and leaving 3,270,248 shares worth $14.7M. The position accounts for 0.49% of the portfolio, ranked #57.

Nantahala Capital Management first reported a position in APYX in Q4 2024 and has held it in 7 quarters since. 68 funds tracked by Wall St. Rank hold APYX as of Q2 2026.

  • Nantahala Capital Management held 3,270,248 shares of Apyx Medical worth $14.7M as of Q2 2026.
  • Nantahala Capital Management sold 170,056 Apyx Medical shares in Q2 2026, an estimated $674K.
  • Apyx Medical made up 0.49% of Nantahala Capital Management's portfolio in Q2 2026, its #57 holding.
  • Nantahala Capital Management first reported a position in Apyx Medical in Q4 2024 and has held it in 7 quarters since.
  • 68 funds tracked by Wall St. Rank held Apyx Medical as of Q2 2026.

Based on Nantahala Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.